{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:18:02Z","timestamp":1761765482369,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":691,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.acvd.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T01:36:12Z","timestamp":1317260172000},"page":"489-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["How can benfluorex-related heart valve disease be identified by echocardiography?"],"prefix":"10.1016","volume":"104","author":[{"given":"Christophe","family":"Tribouilloy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Rusinaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Andr\u00e9jak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2011.07.001_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(09)60252-X","article-title":"Drug-induced fibrotic valvular heart disease","volume":"374","author":"Bhattacharyya","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2011.07.001_bib0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.07.001_bib0015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension study group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.07.001_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/01.WNL.0000083985.00343.F2","article-title":"Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide","volume":"61","author":"Van Camp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.acvd.2011.07.001_bib0025","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.amjcard.2007.06.045","article-title":"Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease","volume":"100","author":"Droogmans","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2011.07.001_bib0030","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1183\/09031936.00086308","article-title":"Fenfluramine-like cardiovascular side-effects of benfluorex","volume":"33","author":"Boutet","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.acvd.2011.07.001_bib0035","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.1371\/journal.pone.0010128","article-title":"Benfluorex and unexplained valvular heart disease: a case-control study","volume":"5","author":"Frachon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2011.07.001_bib0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.acvd.2009.09.015","article-title":"Valvular heart disease associated with benfluorex","volume":"103","author":"Gueffet","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2011.07.001_bib0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.lpm.2011.03.001","article-title":"Number of deaths attributable to benfluorex","volume":"40","author":"Hill","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.acvd.2011.07.001_bib0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ejechocard\/jeq172","article-title":"Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry","volume":"12","author":"Le Ven","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2011.07.001_bib0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1472-8206.2006.00441.x","article-title":"Valvular heart disease in a patient taking benfluorex","volume":"20","author":"Noize","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.acvd.2011.07.001_bib0060","first-page":"215","article-title":"Valvular heart disease associated with benfluorex","volume":"56","author":"Rafel Ribera","year":"2003","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.acvd.2011.07.001_bib0065","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ejechocard\/jeq027","article-title":"Restrictive organic mitral regurgitation associated with benfluorex therapy","volume":"11","author":"Tribouilloy","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2011.07.001_bib0070","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/pds.2044","article-title":"Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus","volume":"19","author":"Weill","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.acvd.2011.07.001_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ejechocard\/jep023","article-title":"Role of echocardiography in toxic heart valvulopathy","volume":"10","author":"Droogmans","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2011.07.001_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/0003-4819-136-6-200203190-00018","article-title":"Regression and progression of valvulopathy associated with fenfluramine and phentermine","volume":"136","author":"Dahl","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2011.07.001_bib0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7015-6-34","article-title":"Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals","volume":"6","author":"Dahl","year":"2008","journal-title":"BMC Med"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213611002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213611002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:39:34Z","timestamp":1761745174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213611002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1875213611002579"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2011.07.001","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How can benfluorex-related heart valve disease be identified by echocardiography?","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2011.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}